GL1X · GenesisL1 explorer

Research workbench

PQR309 - a potent, brain-penetrant, orally bioavailable, pan-class I PI3K/MTOR inhibitor as clinical candidate in oncology

Analyse PQR309 - a potent, brain-penetrant, orally bioavailable, pan-class I PI3K/MTOR… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5OQ4
Type
protein
Length
834 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
EC
2.7.1.153, 2.7.11.1
UniProt
P48736
Ligands
A3W, SO4
Pockets
13 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (EC 2.7.1.153, 2.7.11.1)protein83446% helix, 18% strandP48736

Ligands and binding sites

  • A3W · 5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine · ligand · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111700.810.8287empty
25470.730.8152A3W
3660.700.9620empty
44000.660.8055SO4
52450.610.8041empty

Compared structures

  • 5OQ4 · PQR309 - a Potent, Brain-Penetrant, Orally Bioavailable, pan-Class I PI3K/mTOR Inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.